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LIVING WITH HIV/AIDS
Eficácia antimicrobiana da terapia fotodinâmica no tratamento da 
candidíase oral em pessoas vivendo com HIV/Aids
Eficacia antimicrobiana de la terapia fotodinámica en el tratamiento de la 
candidiasis bucal en personas viviendo con VIH/Sida
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ABSTRACT
Objective: evaluate the antimicrobial efficacy of photodynamic therapy in the treatment of oral candidiasis 
in people living with HIV/aids. Method: experimental, qualitative and descriptive study with 18 people living 
with HIV/aids who presented oral candidiasis, over 18 years of age, who were being treated at the Gaffrée 
and Guinle University Hospital. This group was subdivided into a control group, composed of seven people, 
who received treatment with photodynamic and antifungal therapy, and an experimental group, with 11, who 
received only the photodynamic therapy. The evolution of the treatment of each participant was followed by 
photographic registers in two appointments, initial and final. This research was approved by the Research 
Ethics Committee from the hospital, dictum number 2.431.107. Results: most of the participants showed 
clinical improvement, albeit discrete, and in only one there was clinical worsening. Conclusion: antimicrobial 
photodynamic therapy may be effective in the treatment of oral candidiasis in people living with HIV/aids.
Descriptors: Photodynamic therapy; Oral candidiasis; Opportunistic infections related to AIDS; Fungal 
drug resistance.
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RESUMO
Objetivo: avaliar a eficácia antimicrobiana da terapia fotodinâmica 
no tratamento da candidíase oral em pessoas vivendo com HIV/aids. 
Método: estudo experimental, qualitativo e descritivo com 18 pessoas 
vivendo com HIV/aids que manifestavam a candidíase oral, maiores de 
18 anos, que estavam em tratamento no Hospital Universitário Gaffrée 
e Guinle. Este grupo subdividiu-se em um grupo controle, composto 
por sete pessoas, que recebeu tratamento com a terapia fotodinâmica 
e antifúngicos, e um grupo experimental, com 11, que recebeu apenas 
a terapia fotodinâmica. A evolução do tratamento de cada participante 
foi acompanhada por registros fotográficos em duas consultas, inicial 
e final. Esta pesquisa foi aprovada pelo Comitê de Ética em Pesquisa 
do hospital, parecer número 2.431.107. Resultados: a maioria dos 
participantes apresentou melhora clínica, ainda que discreta, e em 
apenas um houve piora clínica. Conclusão: a terapia fotodinâmica 
antimicrobiana pode ser eficaz no tratamento da candidíase oral em 
pessoas vivendo com HIV/aids.
Descritores: Terapia fotodinâmica; Candidíase oral; Infecções 
oportunistas relacionadas com aids; Resistência fúngica a drogas.
RESUMEN
Objetivo: evaluar la eficacia antimicrobiana de la terapia fotodinámica 
en el tratamiento de la candidiasis bucal en personas que viven con 
VIH/sida. Método: estudio experimental, cualitativo y descriptivo con 
18 personas viviendo con VIH/sida que manifestaban la candidiasis 
bucal, mayores de 18 años, que estaban en tratamiento en el Hospital 
Universitario Gaffrée y Guinle. Este grupo se subdividió en grupo 
control, compuesto por siete personas, que recibió tratamiento con la 
terapia fotodinámica y antifúngicos, y un grupo experimental, con 11, 
que recibió sólo la terapia fotodinámica. La evolución del tratamiento 
de cada participante fue acompañada por registros fotográficos en dos 
consultas, inicial y final. La investigación fue aprobada por el Comité de 
Ética en Investigación del lugar, dictamen número 2.431.107. Resultados: 
la mayoría de los participantes presentó mejoría clínica, aunque discreta, 
y en apenas uno hubo empeoramiento clínico. Conclusión: la terapia 
fotodinámica antimicrobiana puede ser eficaz en el tratamiento de la 
candidiasis bucal en personas que viven con el VIH/sida.
Descriptores: Terapia fotodinámica; Candidiasis bucal; Infecciones 
oportunistas relacionadas con el sida; Resistencia fúngica a las drogas.
INTRODUCTION
Oral candidiasis is the most prevalent oral lesion in 
people living with HIV / AIDS (PLWHA), especially those 
who have not yet started antiretroviral therapy (ART)1, in 
which the pseudomembranous variant of this disease is 
most commonly diagnosed2. Regular distribution of ART 
promoted a significant improvement in the health status 
of PLWHA3, however, the occurrence of oral candidiasis 
in PLWHA under ART is not uncommon4. Clinical 
manifestation is caused by a reduction in T Lymphocyte 
+ CD4 count (LTCD4 +), less than 200 cells/µℓ, and 
an increase in HIV viral load (CV), greater than 3000 
copies/mℓ5. Conventional treatment of oral candidiasis 
is based on the use of topical (e.g. nystatin) and systemic 
(e.g. fluconazole)6 antifungal drugs, however, there are 
limitations: they cause side effects, favor antifungal 
resistance when used for a long time or repeatedly and 
do not prevent recurrence of the injury in the short term7.
The use of photodynamic therapy (PDT) as an 
antimicrobial therapeutic strategy has been widely studied 
in the last decade. Basically, PDT consists in associating 
a light source and a photosensitizing dye compatible 
with this light, applying them to a tissue that has oxygen 
to promote the death by photooxidation of pathogenic 
microorganisms – among them the fungi8.
This technique has shown to be promising in reducing 
C. albicans colonies in in vitro9-11 and in vivo12,13 assays. 
PDT was also effective in the treatment of oral candidiasis 
in PLWHA, without causing side effects, both isolated14 
and when associated with topical antifungals15. Thereby, 
the aim of this paper was to show the antimicrobial efficacy 
of PDT in the treatment of oral candidiasis in PLWHA.
METHODOLOGY
A methodological course of an experimental research 
was performed, qualitative and descriptive, with PLWHA, 
with clinical signs and symptoms of oral candidiasis, over 
18 years old, which were being treated in the wards and 
ambulatories of the Gaffrée and Guinle University Hospital 
(HUGG). Patients using removable oral prostheses, smokers, 
pregnant women, skin cancer in the region, glaucoma and 
cataract patients without medical supervision were not 
included in the evaluations. This research was submitted 
to the HUGG Research Ethics Committee of the Federal 
University of Rio de Janeiro and approved under dictum 
number 2.431.107, and all participants were voluntarily 
invited to participate after signing an informed consent 
form (ICF), notifying them of the risks and benefits of it 
prior to their enrollment.
Participants were separated into two groups (CG, 
control group and EG, experimental group), which 
received different treatments. In the CG group, 14 days 
of conventional antifungal therapy was used (fluconazole, 
nystatin, ketoconazole, etc.), associated with PDT, mediated 
by Therapy EC diode laser (red λ=660nm, power 100mW 
± 20%; and infrared λ=808nm, 100mW power ± 20%; 
DMC manufacturer; São Carlos manufacturing site, 
SP - Brazil), nine joules energy, 90 seconds exposure time; 
with 0.01% methylene blue; with pre-irradiation time of 
four minutes; and with a single irradiation at the injury site. 
The EG was submitted only to PDT, in the same parameters 
used in the CG.
The evolution of the treatment was followed, from a 
qualitative methodological approach, in two moments: 
the first for the collection of information from the 
medical records, evaluation and clinical diagnosis of oral 
candidiasis, prescription of the proposed therapy for each 
group and oral hygiene instruction (OHI), called “D0” (day 
zero); and the second for clinical control after 14 days, 
called “D14” (day 14), in which the clinical evaluation, 
photographic records, reports of patients’ perceptions of 
each treatment used and the OHI were repeated.
Each participant was randomly and sequentially 
numbered, being the first numbered 001 and the last 030. 
Photographs of oral Candida (“before and after”) lesions of 
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each participant were scored (absent = 0, mild = 1, moderate 
= 2 and severe = 3), and also marked with signs, so to 
evaluate if the suggested treatment provided improvement 
(+), worsening (-) or there was no difference (0).
RESULTS 
During this research, 30 participants were evaluated, 
but 12 were excluded because they did not return during 
the period stipulated by the researcher, totaling 18 (100%) 
participants, seven (38,89%) participants in the CG (007, 015, 
016, 018 , 024, 028 and 030) and the other 11 participants 
in the GE (003, 006, 009, 011, 013, 014, 022, 023, 026, 027 
and 029). Of these, 16 (88,89%) were on ART treatment, 
while only two (11,11%) were without ART.
In the CG, four (57,14%) participants (007, 016, 018 
and 030) showed, in the initial  photograph (“before”) taken 
at the first consultation (D0), clinical signs of oral candidiasis 
classified as severe, while the other three (42,86%) (015, 
024, 028) had moderate clinical signs. On the 14th day 
(D14), after photographic evaluation, the total absence of 
clinical signs was verified in two (28,57%) participants (015 
and 030); clinical improvement from moderate to mild in 
two (28,57%) (024 and 028); from severe to mild in one 
(14,29%) (018); and in two (28,57%) (007 and 016) there was 
a slight clinical improvement, but the severe classification 
was maintained (see Tables 1 and 2).
Table 1 - Signal classification of participants in the control 
group (CG) regarding the success / failure of the therapy 
used (Antifungal + PDT) after 14 days..
Participants Score D0 Score D14 Signs
007 3 3 0
015 2 0 +
016 3 3 0
018 3 1 +
024 2 1 +
028 2 1 +
030 3 0 +
Elaborated by the author
Table 2 - Percentage of improvement, worsening or no 
difference in CG treatment after 14 days.
Qualitative Participants Percentage
Improvement 5 71,43%
Worsening 0 0,00%
No difference 2 28,57%
Total 7 100,00%
Elaborated by the author
In the EG, seven (54,54%) participants (003, 009, 
013, 014, 022 and 026) showed, in the initial photograph, 
moderate clinical signs of oral candidiasis on D0; and five 
(45,46%) (006,011,023,027,029) received the classification 
of mild oral candidiasis. In D14, after photographic 
evaluation, it was observed that: the total absence of 
clinical signs of the disease (mild to absent) in two (18,18%) 
participants (006 and 011); clinical improvement from 
moderate to mild in 6 six (54,54%) (003, 009, 013, 014, 
022, and 026); clinical worsening from mild to moderate 
in one (9,09%) (029); and in two (18,18%) (023 and 027), 
no clinically significant differences were observed (see 
Tables 3 and 4).
The clinical worsening of 029 was attributed to his long 
hospitalization, intubation and ventilatory assistance. Even 
in participants who did not change the oral candidiasis 
lesion classification after 14 days (023 and 027), a slight 
clinical improvement was observed.
Table 3 - Signal classification of participants in the 
experimental group (EG) regarding the success/failure of 
the therapy used (PDT) after 14 days.
Participants Score D0 Score D14 Signs
003 2 1 +
006 1 0 +
009 2 1 +
011 1 0 +
013 2 1 +
014 2 1 +
022 2 1 +
023 1 1 0
026 2 1 +
027 1 1 0
029 1 2 -
Elaborated by the author
Table 4 - Percentage of improvement, worsening or no 
difference in EG treatment after 14 days.
Qualitative Participants Percentage
Improvement 8 72,73%
Worsening 1 9,09%
No difference 2 18,18%
Total 11 100,00%
Elaborated by the author
The non-parametric Wilcoxon-Mann-Whitney test 
was applied to statistically compare the difference in the 
proposed treatments for CG and EG. However, there was 
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not enough statistical scientificity to determine in which 
group the treatment was better, due to the small number of 
participants (18) evaluated and the asymmetric number 
of participants in each group (CG = 7 and GE = 11).
DISCUSSION
Oral candidiasis is a very common oral lesion in 
PVHA1. The pseudomembranous form of this disease 
is frequently diagnosed in PLWHA who have not yet 
started ART2 and was observed in this research, precisely 
in two participants (024 and 028) who had not yet chosen 
this therapy. Even with ART reducing the occurrence 
of opportunistic infections and promoting a significant 
improvement in the general health of PLWHA3, it does 
not exempt them from manifesting oral candidiasis4, 
as it was observed in 16 (88,89%) participants in this 
experiment who were under ART. Conventional antifungal 
therapies, responsible for the treatment of oral candidiasis, 
do not always achieve efficacy in the expected time and 
do not prevent recurrence of short-term lesions8,9. These 
findings were confirmed in this experiment, in which 
all participants manifested oral candidiasis, even those 
using antifungals. An experimental study with 21 PLWHA 
showed that fluconazole did not prevent recurrence of 
oral candidiasis when they were reevaluated within 30 
days, whereas in patients receiving PDT, there was no 
recurrence of the lesion during the same reevaluation 
period14. The combination of PDT and fluconazole was 
effective in reducing C. albicans colonies in in vitro10,11 
and in vivo12,13 studies. In this study, participants 015 
and 018, respectively, received PDT/nystatin and PDT/
fluconazole exhibited a reduction in oral candidiasis 
severity ratings when reassessed after 14 days.
CONCLUSION
This research reinforces the importance of the need to 
adopt an adjunctive therapeutic strategy to the conventional 
treatment of oral candidiasis in PLWHA. In this regard, 
PDT can play such a supporting role by reducing the 
prevalence of the disease and its clinical course, as well as 
decreasing antimicrobial resistance to antifungals. Therefore, 
PDT can contribute to the improvement of the patient’s 
general health.
The results of this research indicated that in only one 
patient, who received PDT alone (GE), there was a clinical 
worsening of oral candidiasis. However, this worsening 
cannot be attributed to the experiment, because this patient 
went through a long period of intubation and ventilatory 
assistance, and this condition contributes to Candida 
infection. In all other patients in both groups there was 
improvement, slight improvement or no clinically significant 
differences. In light of this, it has been concluded that 
PDT, combined with red laser and 0.01% methylene blue 
laser, can be considered a promising and safe strategy in 
the treatment of oral candidiasis in PLWHA.
Synergism between PDT and conventional antifungal 
drugs may increase the efficacy of these drugs, reducing 
relapse and reducing the time course of the disease. 
This association can positively impact a shorter 
hospitalization time for the patient and, consequently, 
a decrease in expenses with this patient in health services.
There was no statistical significance in determining 
which group (CG or EG) had the most effective treatment 
due to the small number of participants. For this same 
reason, it was not possible to evaluate whether the use of 
PDT alone, as the only therapeutic strategy in the treatment 
of oral candidiasis in PLWHA, can exhibit the same results 
already established as traditional antifungal therapy. 
These questions reaffirm the need for further research on 
the same theme.
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